EIKON THERAPEUTICS INC (EIKN) Stock Income Statement
NASDAQ:EIKN • US2825641036
Current stock price
10.61 USD
+0.74 (+7.5%)
At close:
10.61 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 338.94M | 260.34M | 265.74M | |||
| Research and Development | 250.32M | 204.54M | 207.26M | |||
| Selling, General, and Administrative Expenses | 88.63M | 55.81M | 58.48M | |||
| Operating Income | -338.94M | -260.34M | -265.74M | |||
| Interest Income/Expense | 14.73M | 16.53M | 23.70M | |||
| Other Income/Expense | -32.00K | -3.00K | 42.00K | |||
| Income Before Taxes | -324.25M | -243.81M | -242.00M | |||
| Net Income | -333.64M | -243.81M | -242.00M | |||
| EBITDA | -320.07M | -245.34M | -254.31M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -6.18 | -4.52 | -4.48 | |||
| Statistics | ||||||
All data in USD